“Identification of synthetic lethality of PRKDC in MYC-dependent human cancers by pooled shRNA
نویسندگان
چکیده
Authors: MANISHHA PATEL ([email protected]) ZONGXIANG ZHOU ([email protected]) JUN LIU ([email protected]) NICHOLAS NG ([email protected]) MINDY HSIEH ([email protected]) ANTHONY ORTH ([email protected]) JOHN WALKER ([email protected]) SERGE BATALOV ([email protected]) JENNIFER HARRIS ([email protected])
منابع مشابه
Synthetic lethal screens as a means to understand and treat MYC-driven cancers.
Although therapeutics against MYC could potentially be used against a wide range of human cancers, MYC-targeted therapies have proven difficult to develop. The convergence of breakthroughs in human genomics and in gene silencing using RNA interference (RNAi) have recently allowed functional interrogation of the genome and systematic identification of synthetic lethal interactions with hyperacti...
متن کاملMyc and mTOR converge on a common node in protein synthesis control that confers synthetic lethality in Myc-driven cancers.
Myc is one of the most commonly deregulated oncogenes in human cancer, yet therapies directly targeting Myc hyperactivation are not presently available in the clinic. The evolutionarily conserved function of Myc in modulating protein synthesis control is critical to the Myc oncogenic program. Indeed, enhancing the protein synthesis capacity of cancer cells directly contributes to their survival...
متن کاملTargeting p300 Addiction in CBP-Deficient Cancers Causes Synthetic Lethality by Apoptotic Cell Death due to Abrogation of MYC Expression.
UNLABELLED Loss-of-function mutations in the CBP/CREBBP gene, which encodes a histone acetyltransferase (HAT), are present in a variety of human tumors, including lung, bladder, gastric, and hematopoietic cancers. Consequently, development of a molecular targeting method capable of specifically killing CBP-deficient cancer cells would greatly improve cancer therapy. Functional screening of synt...
متن کاملmicroRNA-206 impairs c-Myc-driven cancer in a synthetic lethal manner by directly inhibiting MAP3K13
c-Myc (Myc) is one of the most frequently dysregulated oncogenic transcription factors in human cancer. By functionally screening a microRNA (miR) library, we identified miR-206 as being a synthetic lethal in Myc over-expressing human cancer cells. miR-206 inhibited MAP3K13, which resulted in Myc protein de-stabilization, and an inhibition of anchorage-independent growth and in vivo tumorigenes...
متن کاملDevelopment of Synthetic Lethality Anticancer Therapeutics
The concept of synthetic lethality (the creation of a lethal phenotype from the combined effects of mutations in two or more genes) has recently been exploited in various efforts to develop new genotype-selective anticancer therapeutics. These efforts include screening for novel anticancer agents, identifying novel therapeutic targets, characterizing mechanisms of resistance to targeted therapy...
متن کامل